Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
mi
from
Waterloo, IA
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
mi
from
Waterloo, IA
Click here to add this to my saved trials
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
mi
from
Lenexa, KA
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
mi
from
Lenexa, KA
Click here to add this to my saved trials
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
mi
from
Lafayette, LA
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
mi
from
Lafayette, LA
Click here to add this to my saved trials
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
mi
from
Scarborough, ME
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
mi
from
Scarborough, ME
Click here to add this to my saved trials
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
mi
from
Baltimore, MD
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
mi
from
Prince Frederick, MD
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
mi
from
Prince Frederick, MD
Click here to add this to my saved trials
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
mi
from
Lansing, MI
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
mi
from
Lansing, MI
Click here to add this to my saved trials
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
mi
from
Minneapolis, MN
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
mi
from
Reno, NV
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
mi
from
Reno, NV
Click here to add this to my saved trials
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
mi
from
Rochester, NY
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
mi
from
Rochester, NY
Click here to add this to my saved trials
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
mi
from
Durham, NC
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
mi
from
Durham, NC
Click here to add this to my saved trials
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
mi
from
Wilmington, NC
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
mi
from
Wilmington, NC
Click here to add this to my saved trials
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
mi
from
Winston-Salem, NC
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
mi
from
Oklahoma City, OK
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
mi
from
Florence, SC
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
mi
from
Florence, SC
Click here to add this to my saved trials
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
mi
from
Corpus Christi, TX
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
mi
from
Corpus Christi, TX
Click here to add this to my saved trials
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
mi
from
Richardson, TX
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
mi
from
Richardson, TX
Click here to add this to my saved trials
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
mi
from
Milwaukee, WI
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
mi
from
Milwaukee, WI
Click here to add this to my saved trials
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
mi
from
Racine, WI
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
mi
from
Racine, WI
Click here to add this to my saved trials
Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic Syndrome
Probiotic Enteric Regimen For Easing Complications of Transplant : A Pilot Study (PERFECT Trial)
Status: Enrolling
Updated:  2/2/2017
Rutgers Cancer Institute of New Jersey
mi
from
New Brunswick, NJ
Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic Syndrome
Probiotic Enteric Regimen For Easing Complications of Transplant : A Pilot Study (PERFECT Trial)
Status: Enrolling
Updated: 2/2/2017
Rutgers Cancer Institute of New Jersey
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Improving Health of Patients With Colon Cancer Following Surgery: A Trial of SA-ICAN Via Videoconferencing
Improving Health of Patients With Colon Cancer Following Surgery: A Trial of SA-ICAN Via Videoconferencing
Status: Enrolling
Updated:  2/6/2017
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Improving Health of Patients With Colon Cancer Following Surgery: A Trial of SA-ICAN Via Videoconferencing
Improving Health of Patients With Colon Cancer Following Surgery: A Trial of SA-ICAN Via Videoconferencing
Status: Enrolling
Updated: 2/6/2017
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
SentiMag® Intraoperative Comparison in Breast Cancer
A Pivotal, Prospective, Open-Label, Multicenter Paired Comparison Study Of SentiMag/SiennaXP And The Standard Of Care In Patients With Breast Cancer Who Are Undergoing Lymph Node Mapping As Part Of A Sentinel Node Biopsy Procedure
Status: Enrolling
Updated:  2/6/2017
University of California San Diego, Moores Cancer Center
mi
from
La Jolla, CA
SentiMag® Intraoperative Comparison in Breast Cancer
A Pivotal, Prospective, Open-Label, Multicenter Paired Comparison Study Of SentiMag/SiennaXP And The Standard Of Care In Patients With Breast Cancer Who Are Undergoing Lymph Node Mapping As Part Of A Sentinel Node Biopsy Procedure
Status: Enrolling
Updated: 2/6/2017
University of California San Diego, Moores Cancer Center
mi
from
La Jolla, CA
Click here to add this to my saved trials
SentiMag® Intraoperative Comparison in Breast Cancer
A Pivotal, Prospective, Open-Label, Multicenter Paired Comparison Study Of SentiMag/SiennaXP And The Standard Of Care In Patients With Breast Cancer Who Are Undergoing Lymph Node Mapping As Part Of A Sentinel Node Biopsy Procedure
Status: Enrolling
Updated:  2/6/2017
University of California-Davis Comprehensive Cancer Ctr
mi
from
Sacramento, CA
SentiMag® Intraoperative Comparison in Breast Cancer
A Pivotal, Prospective, Open-Label, Multicenter Paired Comparison Study Of SentiMag/SiennaXP And The Standard Of Care In Patients With Breast Cancer Who Are Undergoing Lymph Node Mapping As Part Of A Sentinel Node Biopsy Procedure
Status: Enrolling
Updated: 2/6/2017
University of California-Davis Comprehensive Cancer Ctr
mi
from
Sacramento, CA
Click here to add this to my saved trials
SentiMag® Intraoperative Comparison in Breast Cancer
A Pivotal, Prospective, Open-Label, Multicenter Paired Comparison Study Of SentiMag/SiennaXP And The Standard Of Care In Patients With Breast Cancer Who Are Undergoing Lymph Node Mapping As Part Of A Sentinel Node Biopsy Procedure
Status: Enrolling
Updated:  2/6/2017
UCSF Carol Franc Buck Breast Care Center
mi
from
San Francisco, CA
SentiMag® Intraoperative Comparison in Breast Cancer
A Pivotal, Prospective, Open-Label, Multicenter Paired Comparison Study Of SentiMag/SiennaXP And The Standard Of Care In Patients With Breast Cancer Who Are Undergoing Lymph Node Mapping As Part Of A Sentinel Node Biopsy Procedure
Status: Enrolling
Updated: 2/6/2017
UCSF Carol Franc Buck Breast Care Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
SentiMag® Intraoperative Comparison in Breast Cancer
A Pivotal, Prospective, Open-Label, Multicenter Paired Comparison Study Of SentiMag/SiennaXP And The Standard Of Care In Patients With Breast Cancer Who Are Undergoing Lymph Node Mapping As Part Of A Sentinel Node Biopsy Procedure
Status: Enrolling
Updated:  2/6/2017
Coordinated Health Breast Care Specialists
mi
from
Allentown, PA
SentiMag® Intraoperative Comparison in Breast Cancer
A Pivotal, Prospective, Open-Label, Multicenter Paired Comparison Study Of SentiMag/SiennaXP And The Standard Of Care In Patients With Breast Cancer Who Are Undergoing Lymph Node Mapping As Part Of A Sentinel Node Biopsy Procedure
Status: Enrolling
Updated: 2/6/2017
Coordinated Health Breast Care Specialists
mi
from
Allentown, PA
Click here to add this to my saved trials
SentiMag® Intraoperative Comparison in Breast Cancer
A Pivotal, Prospective, Open-Label, Multicenter Paired Comparison Study Of SentiMag/SiennaXP And The Standard Of Care In Patients With Breast Cancer Who Are Undergoing Lymph Node Mapping As Part Of A Sentinel Node Biopsy Procedure
Status: Enrolling
Updated:  2/6/2017
Dallas Surgical Group
mi
from
Dallas, TX
SentiMag® Intraoperative Comparison in Breast Cancer
A Pivotal, Prospective, Open-Label, Multicenter Paired Comparison Study Of SentiMag/SiennaXP And The Standard Of Care In Patients With Breast Cancer Who Are Undergoing Lymph Node Mapping As Part Of A Sentinel Node Biopsy Procedure
Status: Enrolling
Updated: 2/6/2017
Dallas Surgical Group
mi
from
Dallas, TX
Click here to add this to my saved trials
SentiMag® Intraoperative Comparison in Breast Cancer
A Pivotal, Prospective, Open-Label, Multicenter Paired Comparison Study Of SentiMag/SiennaXP And The Standard Of Care In Patients With Breast Cancer Who Are Undergoing Lymph Node Mapping As Part Of A Sentinel Node Biopsy Procedure
Status: Enrolling
Updated:  2/6/2017
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
SentiMag® Intraoperative Comparison in Breast Cancer
A Pivotal, Prospective, Open-Label, Multicenter Paired Comparison Study Of SentiMag/SiennaXP And The Standard Of Care In Patients With Breast Cancer Who Are Undergoing Lymph Node Mapping As Part Of A Sentinel Node Biopsy Procedure
Status: Enrolling
Updated: 2/6/2017
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
HER2+ Breast Cancer Neo-Adjuvant Coordination of Care Program
HER2+ Breast Cancer Neo-Adjuvant Coordination of Care Program
Status: Enrolling
Updated:  2/6/2017
Marquette General Hospital
mi
from
Marquette, MI
HER2+ Breast Cancer Neo-Adjuvant Coordination of Care Program
HER2+ Breast Cancer Neo-Adjuvant Coordination of Care Program
Status: Enrolling
Updated: 2/6/2017
Marquette General Hospital
mi
from
Marquette, MI
Click here to add this to my saved trials
HER2+ Breast Cancer Neo-Adjuvant Coordination of Care Program
HER2+ Breast Cancer Neo-Adjuvant Coordination of Care Program
Status: Enrolling
Updated:  2/6/2017
DLP Maria Parham Medical Center
mi
from
Henderson, NC
HER2+ Breast Cancer Neo-Adjuvant Coordination of Care Program
HER2+ Breast Cancer Neo-Adjuvant Coordination of Care Program
Status: Enrolling
Updated: 2/6/2017
DLP Maria Parham Medical Center
mi
from
Henderson, NC
Click here to add this to my saved trials
HER2+ Breast Cancer Neo-Adjuvant Coordination of Care Program
HER2+ Breast Cancer Neo-Adjuvant Coordination of Care Program
Status: Enrolling
Updated:  2/6/2017
Lexington Medical Center
mi
from
West Columbia, SC
HER2+ Breast Cancer Neo-Adjuvant Coordination of Care Program
HER2+ Breast Cancer Neo-Adjuvant Coordination of Care Program
Status: Enrolling
Updated: 2/6/2017
Lexington Medical Center
mi
from
West Columbia, SC
Click here to add this to my saved trials
HER2+ Breast Cancer Neo-Adjuvant Coordination of Care Program
HER2+ Breast Cancer Neo-Adjuvant Coordination of Care Program
Status: Enrolling
Updated:  2/6/2017
Augusta Health
mi
from
Fishersville, VA
HER2+ Breast Cancer Neo-Adjuvant Coordination of Care Program
HER2+ Breast Cancer Neo-Adjuvant Coordination of Care Program
Status: Enrolling
Updated: 2/6/2017
Augusta Health
mi
from
Fishersville, VA
Click here to add this to my saved trials
Vitamin D/Calcium Polyp Prevention Study
Vitamin D/Calcium Polyp Prevention Study
Status: Enrolling
Updated:  2/6/2017
University of Southern California
mi
from
Los Angeles, CA
Vitamin D/Calcium Polyp Prevention Study
Vitamin D/Calcium Polyp Prevention Study
Status: Enrolling
Updated: 2/6/2017
University of Southern California
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Vitamin D/Calcium Polyp Prevention Study
Vitamin D/Calcium Polyp Prevention Study
Status: Enrolling
Updated:  2/6/2017
University of Colorado
mi
from
Denver, CO
Vitamin D/Calcium Polyp Prevention Study
Vitamin D/Calcium Polyp Prevention Study
Status: Enrolling
Updated: 2/6/2017
University of Colorado
mi
from
Denver, CO
Click here to add this to my saved trials
Vitamin D/Calcium Polyp Prevention Study
Vitamin D/Calcium Polyp Prevention Study
Status: Enrolling
Updated:  2/6/2017
Emory University
mi
from
Atlanta, GA
Vitamin D/Calcium Polyp Prevention Study
Vitamin D/Calcium Polyp Prevention Study
Status: Enrolling
Updated: 2/6/2017
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Vitamin D/Calcium Polyp Prevention Study
Vitamin D/Calcium Polyp Prevention Study
Status: Enrolling
Updated:  2/6/2017
University of Iowa
mi
from
Iowa City, IA
Vitamin D/Calcium Polyp Prevention Study
Vitamin D/Calcium Polyp Prevention Study
Status: Enrolling
Updated: 2/6/2017
University of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials
Vitamin D/Calcium Polyp Prevention Study
Vitamin D/Calcium Polyp Prevention Study
Status: Enrolling
Updated:  2/6/2017
Univ of Minnesota
mi
from
Minneapolis, MN
Vitamin D/Calcium Polyp Prevention Study
Vitamin D/Calcium Polyp Prevention Study
Status: Enrolling
Updated: 2/6/2017
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Vitamin D/Calcium Polyp Prevention Study
Vitamin D/Calcium Polyp Prevention Study
Status: Enrolling
Updated:  2/6/2017
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Vitamin D/Calcium Polyp Prevention Study
Vitamin D/Calcium Polyp Prevention Study
Status: Enrolling
Updated: 2/6/2017
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Vitamin D/Calcium Polyp Prevention Study
Vitamin D/Calcium Polyp Prevention Study
Status: Enrolling
Updated:  2/6/2017
Univ of North Carolina
mi
from
Chapel Hill, NC
Vitamin D/Calcium Polyp Prevention Study
Vitamin D/Calcium Polyp Prevention Study
Status: Enrolling
Updated: 2/6/2017
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Vitamin D/Calcium Polyp Prevention Study
Vitamin D/Calcium Polyp Prevention Study
Status: Enrolling
Updated:  2/6/2017
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Vitamin D/Calcium Polyp Prevention Study
Vitamin D/Calcium Polyp Prevention Study
Status: Enrolling
Updated: 2/6/2017
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Vitamin D/Calcium Polyp Prevention Study
Vitamin D/Calcium Polyp Prevention Study
Status: Enrolling
Updated:  2/6/2017
University of South Carolina
mi
from
Columbia, SC
Vitamin D/Calcium Polyp Prevention Study
Vitamin D/Calcium Polyp Prevention Study
Status: Enrolling
Updated: 2/6/2017
University of South Carolina
mi
from
Columbia, SC
Click here to add this to my saved trials
Vitamin D/Calcium Polyp Prevention Study
Vitamin D/Calcium Polyp Prevention Study
Status: Enrolling
Updated:  2/6/2017
The University Of Texas
mi
from
Houston, TX
Vitamin D/Calcium Polyp Prevention Study
Vitamin D/Calcium Polyp Prevention Study
Status: Enrolling
Updated: 2/6/2017
The University Of Texas
mi
from
Houston, TX
Click here to add this to my saved trials
Vitamin D/Calcium Polyp Prevention Study
Vitamin D/Calcium Polyp Prevention Study
Status: Enrolling
Updated:  2/6/2017
Univ of Puerto Rico
mi
from
San Juan,
Vitamin D/Calcium Polyp Prevention Study
Vitamin D/Calcium Polyp Prevention Study
Status: Enrolling
Updated: 2/6/2017
Univ of Puerto Rico
mi
from
San Juan,
Click here to add this to my saved trials
A Phase II Study of Continuous Hepatic Arterial Infusion With Floxuridine (FUDR) and Dexamethasone (DEX) in Patients With Unresectable Primary Hepatic Malignancy
A Phase II Study of Continuous Hepatic Arterial Infusion With Floxuridine (FUDR) and Dexamethasone (DEX) in Patients With Unresectable Primary Hepatic Malignancy
Status: Enrolling
Updated:  2/6/2017
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
A Phase II Study of Continuous Hepatic Arterial Infusion With Floxuridine (FUDR) and Dexamethasone (DEX) in Patients With Unresectable Primary Hepatic Malignancy
A Phase II Study of Continuous Hepatic Arterial Infusion With Floxuridine (FUDR) and Dexamethasone (DEX) in Patients With Unresectable Primary Hepatic Malignancy
Status: Enrolling
Updated: 2/6/2017
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients
The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients
Status: Enrolling
Updated:  2/7/2017
Rady Children's Hospital - San Diego
mi
from
San Diego, CA
The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients
The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients
Status: Enrolling
Updated: 2/7/2017
Rady Children's Hospital - San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients
The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients
Status: Enrolling
Updated:  2/7/2017
Riley Hospital for Children at IU Health
mi
from
Indianapolis, IN
The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients
The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients
Status: Enrolling
Updated: 2/7/2017
Riley Hospital for Children at IU Health
mi
from
Indianapolis, IN
Click here to add this to my saved trials
The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients
The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients
Status: Enrolling
Updated:  2/7/2017
Children's Hospital at Montefiore
mi
from
Bronx, NY
The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients
The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients
Status: Enrolling
Updated: 2/7/2017
Children's Hospital at Montefiore
mi
from
Bronx, NY
Click here to add this to my saved trials
The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients
The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients
Status: Enrolling
Updated:  2/7/2017
Maimonides Medical Center
mi
from
Brooklyn, NY
The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients
The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients
Status: Enrolling
Updated: 2/7/2017
Maimonides Medical Center
mi
from
Brooklyn, NY
Click here to add this to my saved trials
The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients
The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients
Status: Enrolling
Updated:  2/7/2017
NYU Langone Medical Center
mi
from
New York, NY
The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients
The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients
Status: Enrolling
Updated: 2/7/2017
NYU Langone Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients
The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients
Status: Enrolling
Updated:  2/7/2017
Mount Sinai Hospital
mi
from
New York, NY
The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients
The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients
Status: Enrolling
Updated: 2/7/2017
Mount Sinai Hospital
mi
from
New York, NY
Click here to add this to my saved trials
PK Study of Oral and IV Clofarabine in High Risk Myelodysplasia+Acute Leukemias
A Pharmacokinetic Study of Oral and Intravenous Clofarabine in Patients With High Risk Myelodysplasia and Acute Leukemias - Determination of Oral Bioavailability and the Effect of Cimetidine on Clofarabine Clearance
Status: Enrolling
Updated:  2/7/2017
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
PK Study of Oral and IV Clofarabine in High Risk Myelodysplasia+Acute Leukemias
A Pharmacokinetic Study of Oral and Intravenous Clofarabine in Patients With High Risk Myelodysplasia and Acute Leukemias - Determination of Oral Bioavailability and the Effect of Cimetidine on Clofarabine Clearance
Status: Enrolling
Updated: 2/7/2017
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials